Intensive sequential chemotherapy for children with acute myelogenous leukemia.
Grier
H E
HE
Division of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston.
Gelber
R D
RD
Clavell
L A
LA
Camitta
B M
BM
Link
M P
MP
Garcea
M J
MJ
Weinstein
H J
HJ
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy* / Q000401:mortality; D015993:Life Tables; D015337:Multicenter Studies as Topic; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction; D015996:Survival Rate; D014481:United States / Q000453:epidemiology; D014750:Vincristine / Q000008:administration & dosage
D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D011239:Prednisolone; D003630:Daunorubicin